Enovis CEO Boosts Stake Amid Stock Decline
Enovis Corp., a prominent medical technology company, has seen its CEO Damien McDonald significantly increase his stake in the firm. On September 4, 2026, McDonald acquired 13,035 shares of Enovis common stock for approximately $249,620. The shares were purchased at prices ranging from $19.10 to $19.16 per share, which is above the current market price of $18.56.
Notably, this purchase comes as Enovis' stock has declined by 25% over the past week and trades near its 52-week low of $18.52. Following the transaction, McDonald directly holds 247,077 shares of Enovis common stock valued at around $4.6 million.
InvestingPro analysis suggests that Enovis' stock is undervalued, with a fair value indicating a 35% upside potential. This has placed it among opportunities on the most undervalued stocks list.